2016 editions
- December 2016
Joao Incio on mechanisms to explain why obesity promotes cancer. - November 2016
Mike Stratton on how mutational changes in a cancer genome can point to the cause of the cancer. - October 2016
Ruth Muschel on a new target for treatments for colorectal cancer. - September 2016
Freddie Hamdy on the effectiveness of treatments for prostate cancer. - August 2016
Moshe Oren discusses the effects of the microenvironment on cancer cells. - July 2016
Richard Gilbertson on the 'bad luck hypothesis' for the cause of cancer. - June 2016
Key advances in clinical trials. - May 2016
Mark Lemmon on the underlying biochemistry of cancer. - April 2016
Roger Stupp on using alternating electric fields as treatment. - March 2016
Charlotte Vrinten on public perception of deaths from cancer. - February 2016
Guillermo Garcia-Manero on myelodysplastic syndromes (MDS). - December 2015/January 2016
Nazneen Rahman on germline genetic screening in ovarian cancer.
EJC News Focus – January 2013
Loading EJC News Focus video
Predictions in Cancer for 2013
What will be the big news in your field in 2013? The availability of new drugs, perhaps? Long awaited phase III data which could set research on a new tack? Or the spiralling costs that will effectively block patients’ access to new treatment approaches? In this month’s EJC News Focus, Helen Saul asks Mary O’Brien, Richard Marais, Roger Stupp, Manuela Schmidinger and David Cameron what they expect to be the key issues in their field in the coming year.